Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
A Case of Dense Deposit Disease with Nivolumab and Ipilimumab Therapy in a Patient with Malignant Pleural Mesothelioma (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1260; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Electron microscopy was therefore essential for the detailed evaluation of ICI-induced membranoproliferative glomerulonephritis. Complement-mediated glomerular disease should be considered in patients who develop urinary abnormalities and renal dysfunction during ICI therapy." 
Clinical • Complement-mediated Rare Disorders • Glomerulonephritis • Lupus Nephritis • Malignant Pleural Mesothelioma • Mesothelioma • Nephrology • Pleural Mesothelioma • Renal Disease • Solid Tumor
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4557931
 
Shohei Terada; Ryosuke Yamamura; Yu Nagayoshi; Daisuke Fujimoto; Tomoko Kanki; Terumasa Nakagawa; Yoshikazu Miyasato; Teruhiko Mizumoto; Yutaka Kakizoe; Masataka Adachi; Yuichiro Izumi; Takashige Kuwabara; Yukimasa Koda; Hideki Yokoi
 
Oct 2, 2026
 
Prev Next